Evolve Biosystems Stock
Evolve BioSystems is developing the next generation of products to establish, restore, and maintain a healthy newborn gut microbiome.
Sign up today and learn more about Evolve Biosystems Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Evolve Biosystems Stock
Evolve Biosystems is a spin-out from the Foods For Health Institute (FFHI) at the University of California, Davis. The company builds on more than a decade of research into the infant biome and its intimate interaction with breast milk components established by the founding scientists including Bruce German, David Mills, Carlito Lebrilla, Daniela Barile and Samara Freeman. Their fundamental research and translational clinical trials have been enabled by more than $15 million in federal and private grants since 2004.
Investors
Bill & Melinda Gates Foundation
Apeel Sciences, Pivot Bio, Butterfly Network, Schrodinger, Evolve Biosystems, Heliogen
Funding History
| August 2015 | $9.0M |
|---|---|
| May 2017 | $20.0M |
| June 2018 | $40.0M |
Management
Director, IP & Regulatory Affairs
Samara Freeman
Co-Founder
Carlito Lebrilla
CEO
David Kyle
Co-Founder
Bruce German
Co-Founder
David Mills
Co-Founder
Daniela Barile
Press
Global University Venturing - Jun, 14 2018
Evolve BioSystems digests $40m series CPE Hub (blog) - Jun, 13 2018
Evolve BioSystems, UC Davis baby-probiotic spinout, is going global with new $40M financingPR Newswire (press release) - Dec, 6 2017
Evolve BioSystems' Activated B. infantis EVC001 Demonstrates Substantial and Persistent Remodeling of the Infant ...Marketwired (press release) - Aug, 1 2017
Evolve BioSystems, Inc. announces Timothy B. Brown as new CEO, David Kyle named Executive Chairman and Chief ...Marketwired (press release) - May, 30 2017
Evolve BioSystems Completes $20 Million Series B FinancingEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
